PDGFRB and neutropenia: Western blot analysis of the phosphorylation of PDGFR-ß revealed significant upregulation in the group with LPS during neutropenia recovery, whereas the group treated with imatinib or nilotinib there was a reduction toward control levels (Figure 5).